FGFR2 and colorectal cancer: High expression and activation of FGFR2 was observed in NCI-H716 colorectal cancer cells, and FGFR2-selective small molecule inhibitors or FGFR2-specific shRNA strongly inhibited cell viability in vitro, indicating addiction of NCI-H716 cells to FGFR2 [17].